Fudan Science and Technology Fund

Fudan Science and Technology Fund (复旦科创) shows up in elsewhere's corpus mainly through its 2026 deal activity rather than any dedicated profile — elsewhere hasn't covered its founding background or fund size directly. What the record does show is an active early-stage investor across biotech and embodied AI: it co-led Raincong Biotech's nearly RMB 100 million Series C alongside Qiming Venture Partners in March 2026 , joined the investor syndicate in embodied-AI startup Sudu Tech alongside CATL's Puquan Capital, Alibaba, Hillhouse Ventures, Tencent, IDG and others in April 2026 , and co-led physical-intelligence startup FeiJieKeSi's several-hundred-million-yuan Series A1 with TEDA Science & Technology Investment and Songhai Capital in August 2026, per Yunqi Partners . Its name and deal pattern suggest a Fudan-affiliated technology commercialization vehicle — elsewhere's coverage notes, for instance, that a Shanghai biotech translation fund backed a Fudan spinout project — but the corpus doesn't explicitly establish the fund's relationship to Fudan University, so that connection shouldn't be taken as confirmed.